Purdue Pharma Sentencing Clears Path for $7.5 Billion Opioid Settlement

Press Release: April 29, 2026 - Indiana has been hit hard over the years by the opioid epidemic, with families across the state continuing to experience the devastating effects of prescription opioid misuse, addiction, and illicit drug poisoning. On April 28, 2026, Purdue Pharma, the manufacturer of OxyContin, was sentenced in federal court and ordered to pay $5.5 billion for its role in fueling the opioid epidemic in the United States. The sentencing marks another major chapter in one of the most devastating public health crises in our nation’s history and one that continues to impact families in communities like ours every day.

Purdue previously pleaded guilty in 2020 to federal charges tied to its role in aggressively marketing opioid medications, misleading federal regulators, and paying doctors to increase opioid prescriptions. According to court records, the company admitted to illegally promoting its opioid products, deceiving the Drug Enforcement Administration about the effectiveness of its monitoring programs, and using financial incentives through speaker programs to encourage prescribing. These actions contributed to the widespread misuse of prescription opioids and helped fuel a crisis that has taken countless lives across the country.

The court ordered Purdue to pay a criminal fine of $3.544 billion, which will be assessed in connection with the bankruptcy proceedings, and an additional $2 billion in criminal forfeiture, the DOJ says.

Purdue announced that it will permanently cease operations on May 1, 2026. Its remaining assets will transfer to a newly formed company, Knoa Pharma, which is expected to focus on addiction treatment and overdose reversal medications moving forward.

Indiana state and local governments are expected to receive up to $100 million from the national $7.4 billion opioid settlement with the Purdue Pharma and the Sackler family.